16th Jan 2020 – Helius Medical Technologies, Inc. issued an announcement, which is summarized as follows：
Helius today announced that it has entered into an agreement with the University Health Network (UHN) to perform a clinical experience program to enable it and three independent neurorehabilitation clinics in Canada to evaluate the Company’s Portable Neuromodulation Stimulator (PoNS?) device, in conjunction with physical therapy, on patients with chronic balance deficit due to mild-to-moderate traumatic brain injury (“mmTBI”) in Canada.
“We are honored that University Health Network, is participating with Helius in this clinical program and coordinating clinical activities with independent neurorehabilitation centers in Canada. This clinical experience program will help us understand how this technology can fit in the treatment of patients who have suffered a mmTBI resulting in a chronic balance deficit,” said Philippe Deschamps, Chief Executive Officer of Helius.
The original website link：
https://heliusmedical.com/index.php/newsroom/news-release/2020/314-